Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (141-150 of 291) with videos related to

Pageof 30
Sort By:
Digestive Diseases and Sciences|March 18, 2008
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus settingTomoharu Miyashita, Furhawn A Shah, Guy P Marti, et al.
JCI Insight|October 10, 2022
Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trialsDimitrios N Sidiropoulos, Genevieve L Stein-O'Brien, Ludmila Danilova, et al.
The Journal of Experimental Medicine|May 11, 2005
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune responseAnne M Ercolini, Brian H Ladle, Elizabeth A Manning, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal CancerEric S Christenson, Valerie Lee, Hao Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigenSatoshi Murata, Brian H Ladle, Peter S Kim, et al.
The Journal of Clinical Investigation|April 10, 2008
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCsPeter S Kim, Todd D Armstrong, Hong Song, et al.
Cancer Immunology Research|February 5, 2016
Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic CancerDarshil T Jhaveri, Min-Sik Kim, Elizabeth D Thompson, et al.
Journal for Immunotherapy of Cancer|September 4, 2021
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACRNicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, et al.
The Journal of Clinical Investigation|September 17, 2019
Equity and diversity in academic medicine: a perspective from the JCI editorsLinda Ms Resar, Elizabeth M Jaffee, Mary Armanios, et al.
Theranostics|April 14, 2025
EphA2-targeted alpha-particle theranostics for enhancing PDAC treatmentAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Pageof 30

Showing results (141-150 of 291) with videos related to

Sort By:
Pageof 30
Digestive Diseases and Sciences|March 18, 2008
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus settingTomoharu Miyashita, Furhawn A Shah, Guy P Marti, et al.
JCI Insight|October 10, 2022
Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trialsDimitrios N Sidiropoulos, Genevieve L Stein-O'Brien, Ludmila Danilova, et al.
The Journal of Experimental Medicine|May 11, 2005
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune responseAnne M Ercolini, Brian H Ladle, Elizabeth A Manning, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal CancerEric S Christenson, Valerie Lee, Hao Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigenSatoshi Murata, Brian H Ladle, Peter S Kim, et al.
The Journal of Clinical Investigation|April 10, 2008
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCsPeter S Kim, Todd D Armstrong, Hong Song, et al.
Cancer Immunology Research|February 5, 2016
Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic CancerDarshil T Jhaveri, Min-Sik Kim, Elizabeth D Thompson, et al.
Journal for Immunotherapy of Cancer|September 4, 2021
Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACRNicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, et al.
The Journal of Clinical Investigation|September 17, 2019
Equity and diversity in academic medicine: a perspective from the JCI editorsLinda Ms Resar, Elizabeth M Jaffee, Mary Armanios, et al.
Theranostics|April 14, 2025
EphA2-targeted alpha-particle theranostics for enhancing PDAC treatmentAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Pageof 30